Regularized Single-cell Imaging Enables Generalizable AI models for Stain-free Cell Viability Screening

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 2,831 characters · extracted from oa-doi-fallback · click to expand
Abstract Cell viability assays are essential tools in biomedical research and drug development. Artificial intelligence (AI) offers the potential to simplify these assays by predicting cell viability directly from brightfield microscopy images, but current models lack generalizability across diverse cell types and treatments. Here, we introduce a strategy called “regularized imaging”, where single cells are isolated in nanowells to generate standardized image patches that simplify segmentation and improve training data quality. We trained our model using example images of live and dead cells from a single cell line exposed to four cytotoxic conditions (ethanol, andrographolide, daunorubicin, and serum starvation). Despite this narrow training dataset, the resulting model accurately identified live and dead cells after treatment by previously unseen compounds, successfully replicating dose-response curves comparable to fluorescence live/dead assays. Importantly, this model effectively generalized across diverse cell types, including both adherent and suspension cells. Additionally, microscopy-based cell viability analysis is non-destructive, enabling repeated measurements to perform kinetic studies to distinguish between fast- and slow-acting compounds. Our findings highlight how regularized single cell imaging enables the training of broadly generalizable AI models to recognize biologically relevant cell features for label-free cell screening workflows. One-sentence Summary Regularized single-cell imaging in nanowells enables training of generalizable AI models for accurate, stain-free viability screening across previously unseen cell types and contexts. Competing Interest Statement S.G.B. and H.M. have financial interest in ImageCyte Technologies, which is commercializing the nanowell-in-microwell plates. Some of the authors are inventors on patent applications own by the University of British Columbia. Footnotes Code and Data availability All source code, dataset, and trained models have been deposited at https://github.com/Pan-De/stain-free-viability-screening-using-nanowells Funding Statement This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (2020-05412, 2020-00530, 590749-24). P.D. acknowledges funding from the China Scholarship Council and the Tai Hung Fai Charitable Foundation. S.G.B. acknowledges funding from the Society for Laboratory Automation and Screening Graduate Education Fellowship Grant. Conflict of Interest Disclosure S.G.B. and H.M. have financial interest in ImageCyte Technologies, which is commercializing the nanowell-in-microwell plates. Some of the authors are inventors on patent applications own by the University of British Columbia. https://github.com/Pan-De/stain-free-viability-screening-using-nanowells

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00